TLIS

Talis Biomedical (TLIS)

Talis Biomedical Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TLIS

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/08	21 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TLIS	Talis Biomedical Corporation
2024/01/27	06 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TLIS	Talis Biomedical Corporation
2023/11/14	22 : 00	GlobeNewswire Inc.	Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash	NASDAQ:TLIS	Talis Biomedical Corporation
2023/09/02	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/11	06 : 01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/11	05 : 46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/11	05 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/11	05 : 05	GlobeNewswire Inc.	Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/03	21 : 00	GlobeNewswire Inc.	Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/02	21 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/02	21 : 17	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/02	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TLIS	Talis Biomedical Corporation
2023/08/02	21 : 00	GlobeNewswire Inc.	Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/07/27	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TLIS	Talis Biomedical Corporation
2023/07/27	21 : 00	GlobeNewswire Inc.	New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu	NASDAQ:TLIS	Talis Biomedical Corporation
2023/07/24	21 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TLIS	Talis Biomedical Corporation
2023/07/24	21 : 00	GlobeNewswire Inc.	Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:TLIS	Talis Biomedical Corporation
2023/07/19	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TLIS	Talis Biomedical Corporation
2023/07/05	21 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TLIS	Talis Biomedical Corporation
2023/07/05	21 : 00	GlobeNewswire Inc.	Talis Biomedical Announces 1-for-15 Reverse Stock Split	NASDAQ:TLIS	Talis Biomedical Corporation
2023/06/14	05 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/06/13	06 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/06/13	06 : 26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/06/13	06 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/06/13	06 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/06/13	06 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/06/10	05 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/05/23	21 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TLIS	Talis Biomedical Corporation
2023/05/23	21 : 00	GlobeNewswire Inc.	Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director	NASDAQ:TLIS	Talis Biomedical Corporation
2023/05/12	05 : 38	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TLIS	Talis Biomedical Corporation